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1. Introduction  
Endometriosis is a common gynecological disease. It is unique to have benign histology but 
with malignant characteristics. Easy recurrence, multiple organ involvement and malignant 
transformation potential make endometriosis a complex disease. Multi-factors contribute to 
the pathophysiology. Recently, endometriosis has been regarded as a stem cell disease 
(Sasson & Taylor, 2008).  Some studies have provided evidence of the possible existence of 
stem cells in endometrial tissue (Gargett et al., 2004, 2007). We successfully isolated eutopic 
and ectopic endometrial mesenchymal stem cells (EN-MSCs) derived from one donor to 
examine the genetic difference analysis that provided a powerful tool for investigating the 
disease origin (Kao et al., 2011). Our results are consistent with the concept that 
endometriosis is a stem cell disease. We identified and characterized the MSCs from ectopic 
and eutopic endometrium by in vitro cell characteristics, including serpiginous morphology, 
surface biomarkers, a lack of gap junctional intercellular communication and the ability of 
differentiation and transdifferentiation into adipocytes, osteocytes, chondrocytes, neural cell 
and cardiomyocytes. In an in vivo animal study, we found the ability of invasion in eutopic 
and ectopic MSC. 
The origins of endometrium stem cells are still under debate. Bone marrow is one of the 
origins. Bone marrow MSC circulates to the endometrium and reprograms into the 
endometrial MSC.  
Aims of the chapter are to discuss about the endometrial stem cell identification and 
characterization and the stem cell theory of endometriosis will be discussed by search from 
the PubMed publications. The results will update our knowledge of the novel theory --- 
stem cell as the root of endometriosis. 
2. Stem cells as the novel pathophysiology of endometriosis 
2.1 Evidence of stem cell in the endometrium 
The presence of endometrium stem cells can be identified by the property of clonogenicity, 
side population cells, stem cell markers, multipotent cells, xeno-transplantation. Expression 
of pluripotent marker such as Oct-4, and the stem cell factor in ectopic endometrium suggest 
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that endometriosis has a stem cell origin (Pacchiarottic et al., 2011). There are two types of 
endometrium mesenchymal stem cells, one derived from the epitheilium and the other one 
from the stromal cells. The locations of these putative stem cells are supposed to be in the 
basalis of the endometrium (Figure 1). Some stem cell markers, for example, the RNA-
binding protein Musashi-1 in colocalization with Notch-1 and telomerase increased in the 
basalis (Gotte et al., 2008). Recent study showed the endothelial progenitor/stem cells might 
reside in the endothelial cells (Maruyama et al., 2010). Some report showed the stem cell 
activity in endometrium through a stem cell niche with numbers of stem cells instead of a 
single stem cell (Kim et al., 2005). The function of endometrial stem cell/progenitor cell has 
be demonstrated to repair the damaged uterine surface in mouse model (Kaitu’u-Lino et al., 
2010). 
2.1.1 Cell cloning studies 
The classic adult stem cell property, namely clonogenicity, is defined as a single cell to 
initiate a colony of cells when cultured at a single cell dilution condition. Both epithelium 
and stroma cells were reported to show clonogenicity (Gargett et al., 2007). The stromal 
cells display more clonogenicity than the epithelium cells. Both epithelium and stromal 
cells can develop large and small colonies. The large colonies were supposed to be 
initiated by stem cells while the small colonies by more mature transit amplifying cells 
(Figure 2). 
2.1.2 Side population cells 
Side population (SP) cells with the expression of ABCG2, which is a plasma membrane 
transporter, can extrude the DNA binding dye from cells. The cells in the side population 
are clonogenic and appear to be a universal marker of endometrial stem cell activity. SP 
cells are detected as a small fraction of cells within the endometrium after incubation with 
the Hoechst 33342 DNA binding dye. Recent study (Cervell et al., 2011) confirms the SP 
cells displays endometrial stem cell characteristics in molecular markers of 
undifferentiated cells (Oct-4, GDF3, Nanog, DNMT3betta, GABR3). Phenotype analysis 
verifies epithelial (CD9+), or stromal (vimentin+) cell origin. The mesenchymal markers 
(CD90+, CD73+, CD45-) are expressed in SP. All these data imply SP containing the 
endometrial stem cells. 
2.1.3 Stem cell marker and expression of stemness-related genes 
Since the lack of universal stem cell-specific markers, adult stem cells are difficult to purify. 
This is the same in the case of endometrial stem cells. Various markers or combinations of 
markers have been reported to purify endometrium MSC (Table 1). 
The stem cell markers in endometrium are not fully recognized. Some studied have 
examined the expression of stem cell markers in the endometrium. Oct-4, bcl-2, c-kit 
(CD117), CD 34, CD45, CD7, CD56 are reported (Mattai C et al., 2006; Cho et al., 2004; Lnych 
et al., 2007). Forte et al (Forte et al., 2009) studied the expression a panel of stemness related 
genes in the human endometriotic and endometrial samples. They found genes UTF1, TCL1, 
and ZFP42 showed higher frequency of expression in endometriosis than in endometrium. 
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The presence of the stem cell markers in the endometrium and endometriotic samples 
suggest stem cell contributes to the pathogenesis of endometriosis.  
2.1.4 Multipotent cells identified in human endometrium 
Schwab & Gargett isolated mesenchymal stem-like cells from human endometrium in 2007 
(Schwab & Gargett, 2007). They identified the endometrial stromal cells with the capacity of 
differentiated into cells of adipogenic, myogenic, osteogenic, and chondrogenic cell lineages. 
In the same year, the other research group (Wolff et al., 2007) also identified the 
chondrocytes from the human endometrium. These reports demonstrated the multipotent 
stem cells in the human endometrium. These multipotent endometrial stem/progenitor cells 
have reported to differentiate into 9 lineages: cardiomyocytic, respiratory epithelial, 
neurocytic, myocytic, endothelial, pancreatic, hepatic, adipocytic and osteogenic (Meng et 
al., 2007). 
2.1.5 Xenotransplantation 
Some studies have demonstrated the formation of endometriotic lesion formation after 
transplantation of human endometrium into the immunodeficient mice such as severe 
combined immunodeficiency (SCID) and nude mice. Singly dispersed human endometrial 
cells were transplanted under the kidney capsules of non-obese diabetic (NOD)/SCID mice. 
They unveiled the reconstruction of endometrium by showing the formation of chimeric 
vessels, tortuous endometrial glands, tissue breakdown and bleeding (Masuda et al., PNAS 
2007). Our previous investigation revealed the invasion and angiogenesis character after 
implanting with scaffolds seeded with eutopic or ectopic endometrial MSCs (Kao et al., 
2011). 
2.2 Source of the endometrium stem cells 
Endometrium from the eutopic (inside the uterine cavity) or ectopic (outside of the uterine 
cavity), from the menstrual blood and bone marrow are the origin of the putative 
endometrial stem cells. 
2.2.1 Isolation and culture of putative eutopic and ectopic endometrial mesenchymal 
stem cells 
Endometrial stem cells can be cultivated from the endometrium epithelium and stroma. We 
isolated the putative eutopic and ectopic endometrial mesenchymal stem cells from the 
cases of endometriosis. According to our previous report (Kao et al., 2011), endometrial 
stromal cells were cultured from the tissue of eutopic and ectopic endometrium (from the 
endometrioma). At early passage (passage 5), endometrial stromal cells were seeded in 
triplicate at very low density (200 cells per 100 mm dish) in Dulbecco’s modified Eagles’s 
medium-Ham’s F12 medium. After 21 days of incubation, large colonies were isolated and 
trypsinized into single cells. The diluted single cells were seeded in 96-well plates, clonally 
derived proliferating colonies were individually trypsinized and culture in a 100-mm dish 
after culture for 14 days. These isolated stem/progenitor cells illustrated the differentiation 
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into mesoderm (adipogenesis, chondrogenesis, osteogenesis and cardiogenesis) and 
ectoderm (neurogenesis) (Figure 2).  
2.2.2 Menstrual blood plays a role in the endometrial stem cells 
Musina et al. isolated endometrium stem cells from the menstrual blood (Musina et al., 
2008). The morphology resembled mesenchymal stem cells. The stem cells express CD44, 
CD90, CD 34, CD45, CD105/Endoglin. Cell differentiation revealed adipocytes, 
osteoblasts.  
2.2.3 Bone marrow contributes to the sources of endometrial stem cells and 
pathogenesis of endometriosis 
Currently, the ultimate source of endometrial stem cells is uncertain. Bone marrow 
derived stem cells (BMDCs) include hematopoietic stem cells (HSC) and MSC. BMDCs 
have been reported to be capable of transdifferentiation into hepatocytes, endothelial 
cells, neurons, cardiomyocyte, skin, gastrointestinal epithelium and endometrium (Taylor 
et al., 2004; Alison et al., 2000; Mezey et al., 2003; Quanini et al., 2002). Taylor et al. first 
provided the evidence of BMDCs as the sources of endometrial stem cells (Taylor et al., 
2004). After bone marrow transplantation, they detected the endometrial epithelial cells 
and stromal cells with the donor human leukocyte antigen (HLA) in the recipient’s 
endometrial samples. Another study observed the BMDCs derived from male donor mice 
engrafted the murine recipient endometrium (Du & Taylor, 2007). Although the 
transplanted BMDCs present in a small fraction (less than 0.01%), they could differentiate 
into endometrial cells in the uterus. Some novel theory of BMDCs in endometriosis 
pathogenesis was recently arisen. Bone marrow–derived circulating endothelial 
progenitor cells are recruited and incorporated into the vasculature of endometriotic 
lesions, thus contributing to the development of endometriosis (Matthias et al., 2011). In 
human studies, the donor BMDCs could transdifferentiate into the endometrial 
endothelial cells in a bone marrow transplantation recipient (Mints et al., 2008). BMDCs 
from human male donors were reported to differentiate into endometrial glands in a 
female transplant recipient (Ikoma et al., 2009). These data provide the evidence BMDCs 
as possible sources of endometrial stem/progenitor cells and endothelial progenitor cells. 
2.2.4 Circulating endothelial progenitor cells (EPCs) contribute to the vascularization 
of endometriotic lesions 
Endometriosis represents an angiogenic disease, rapid vascularization is essential to foster 
the ectopic endometrium survival and growth. One canonical characteristic of 
endometiosis is the vascularized endometriotic lesions inside the peritoneal cavity. Recent 
study (Matthias et al., 2011) indicates for the first time the circulating EPCs from the bone 
marrow contribute a relative high fraction (about 15%) of the microvascular networks in 
the engrafting endometriotic lesions in mice model. The recruited EPCs may contribute to 
the process of vasculogenensis (de novo generation of endothelial cells) (Figure 5). These 
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2.3 Endometrial stem cells as the pathogenesis and therapeutic target for 
endometriosis 
2.3.1 Stem cells as a novel pathogenesis of endometriosis 
Endometriosis is a multifactorial disease, the pathogenesis includes retrograde of 
endometrial cells, immunological insufficiency, genetics (Juo et al, 2006; 2009), metaplasia, 
and environmental hormone disruptor (Huang et al., 2011). Endometrial stem cells were 
identified in the endometrioma cyst walls (Chan et al., 2011; Kao et al., 2011).  
Some hypotheses suggest the theory of stem cell in the pathogenesis of endometriosis 
(Figueira et al., 2011; Kao et al., 2010). Endometrium stem cells reside in the basalis layer can 
flux through the tubes and establish endometriotic lesions in the peritoneum. The 
stimulatory factors consisting of genetic, immunological and inflammatory, angiogenesis 
factors (Figure 6) promote the growth. An alternative hypothesis explores the extrauterine 
stem/progenitor cells (for example, from reprogram of bone marrow MSCs and circulating 
EPCs) function in the pathogenesis of endometriosis. 
2.3.2 Therapeutic potential of human endometrial stem cells 
Therapeutic potential of human endometrial stem cells has attracted interest of the 
researchers. Endometrial stem cells were obtained from nine healthy women and were 
transformed into the dopaminergic nerve cells. These cells were transplanted into the 
Parkinson-mice model (Wolff et al., 2010) and restored function of brain cells damage by 
producing dopamine.  
The stem cell theory of endometriosis makes the advancement of targeting stem cells as the 
novel treatment. Stem cells flux and fostered by the peritoneal environment. The stem cells 
grow into endometriosis with increased survival and proliferative capacity along with 
environmental factors that contribute to stem cell survival and propagation. The treatment 
target can focus on the inhibition of stem cell flux and initiation and progression of 
endometriosis. Recent report (Zhou et al., 2011) cigarette smoke inhibits recruitment of bone 
marrow derived stem cells to the uterus. This finding is compatible with the epidemiological 
data of low incidence of endometriosis cases in smokers. Further investigation on the 
individual components of tobacco may unveil useful treatment in endometriosis. Our recent 
study reveals interleukin-1 beta can upregulate cyclooxygenase-2 and enhance invasion of 
human MSC derived from the ectopic endometrium (Kao et al., 2011). These results imply 
the interleukin-1 betta could be the targeting signalling. Stem cell therapy has been used in 
the lupus through anti-inflammatory activity (Traynor et al., 2002). Based on the same 
concept, bone marrow derived mononuclear stem cells has been transplanted in the 
experimental Wistar rats (Kondo et al., 2011). The expression of the inflammatory cytokines 
tumor necrosis factor-alpha (TNF-alpha) and vascular endothelial growth factor (VEGF) in 
the endometriotic implant decreased without reducing the lesion surface area. This provides 
the evidence that stem cells home the ectopic tissue to reduce the inflammatory process. 
This conflicts with the stem cell theory, which may indicate when the stem cells derived 
from the bone marrow, when they engrafte the endometrium, they are modified in the gene 
expression, what will lead to the development of the endometriosis. The modified stem cells 
play different function as those original stem cells used for therapy. Other targeting of 
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inhibition in signalling pathways by stem cells and the microenvironment, self- renew 
pathway blocking, cell recruitment, flux and adhesion prevention will represent novel 







Fig. 1. The location of putative progenitor/stem cells is identified in the basalis of the 
endometrium. MSC denotes mesenchymal stem cells, and EPC indicates endothelial 
progenitor cells. (Modified from Maruyama et al., 2010) 
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Fig. 2. Purification of stem cells from endometrial stromal cells. Large and small colonies 
develop after single cell limiting dilution. The large colonies are cultivated for stem cells 
identification.  
 
Fig. 3. Isolation and differentiation of endometrial stem/progenitor cells. Endometrial 
stem/progenitor cells can be isolated from endometrial epithelium and stromal cells. These 
cells can differentiated into 9 lineages, including adipocyte, myocyte, respiratory 
epithelium, neurocyte, osteogenic, cardiomyocytic, endothelial, pancreatic and hepatic cells.       
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Fig. 4. Mesenchymal stem cells derived from eutopic and ectopic endometrial stromal cells 
differentiate into mesoderm and ectoderm lineages. 
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Fig. 5. Endothelial progenitor cells are mobilized and recruited to the endometriotic lesions, 
subsequently vasculogenensis (de novo generation of endothelial cells) occurs (modified 
from Laschke et al., 2011). 
 
MSC indicates mesenchymal stem cell.  
EPC means endothelial progenitor cell. 
Fig. 6. The possible theory of endometrial stem/progenitor cells in the pathogenesis of 
endometriosis. The endometrial stem cells reflux to the peritoneum, and the 
microenvironmental factors such as growth factors, cytokines etc., stimulate the stem cells 
function (cell renew, invasion and cell differentiation). Bone marrow derived MSC and EPC 
may also contribute to the pathogenesis as described in the text.  
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Biomarker Relevance/function Expression 
Oct-4 Stem cell Positive 
hTERT Telomerase reverse transcriptase Positive 
CD9 MSC/angiogenesis  Positive 
CD29 MSC/adhesion molecule Positive 
CD41a MSC/fibrinogen receptor Positive 
CD44 MSC/hyaluronic acid receptor Positive 
CD73 MSC/migration Positive 
CD90 MSC/marker of T cells, hematopoietic and MSC Positive 
CD105 MSC Positive 
CD49f  MSC Positive 
Musashi-1 Endometrial stem cell Positive 
CD34 Hematopoietic stem cell Negative 
CD45 Leukocyte cell Negative 
SSEA-4 Embryonic stem cell Negative 
Nanog Embryonic stem cell Negative 
MSC: mesenchymal stem cell 
Modified from Meng et al., 2007 
 
Table 1. Biomarkers of endometrial mesenchymal stem cells. 
3. Conclusion 
Since the retrograde implantation theory developed in the 1920s by Sympson, the etiology of 
endometriosis involves a complex interplay of genetic, immunologic, inflammatory and 
environmental factors. Nevertheless, endometriosis remains an enigmatic disease to cause 
pelvic pain and infertility. The characteristics of recurrence and wide spray make the disease 
malignant-like. Stem cell theory opens the latest advanced avenue for etiology of 
endometriosis. Increasing studies illustrate the presence of endometrial stem/progenitor 
cells, either from the residing cells in the endometrium or reprogram of bone marrow MSC. 
EPC from the bone marrow can contribute to the de novo angiogenesis. The EPC enhances   
endometriosis formation. Endometriosis is a recurrent disease, thus making the treatment 
costly and psychologically debilitating. Novel treatment modalities include selective ER 
modulators, tissue factor (the initiator of the hemostatic cascade) targets, statins and 
angiogenic blockers, immunoconjugate molecule and stem cells. Administration of 
endometrial stem cells to the disease model could suppress the immunological reaction, and 
was supposed to have potential in the treatment. Other therapy modalities to target the stem 
cells flux, adhesion and signalling control pathway are novel treatment strategies. 
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endometriosis. Key features of the book include overviews of endometriosis; endometrial angiogenesis, stem
cells involvement, immunological and hormonal aspects related to the disease pathogenesis; recent research
reports on infertility, endometrial receptivity, ovarian cancer and altered gene expression associated with
endometriosis; various predictive markers, and imaging modalities including MRI and ultrasound for efficient
diagnosis; as well as current non-hormonal and hormonal treatment strategies This book is expected to be a
valuable resource for clinicians, scientists and students who would like to have an improved understanding of
endometriosis and also appreciate recent research trends associated with this disease.
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